NSE · Healthcare · Drug Manufacturers - General
EPS came in at 36.26 against a street estimate of 39.30 — a miss of 7.7%.
with an average price target of ₹4,339.67.
| Holder | Stake |
|---|---|
| LIFE INSURANCE CORPORATION OF INDIA - P & GS Fund | 5.95% |
| Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund | 4.08% |
| General Insurance Corporation of India | 2.56% |
| Aditya Birla Sun Life Trustee Private Limited A/C - Aditya Birla Sun Life Mnc Fund | 2.32% |
| SBI Elss Tax Saver Fund | 1.73% |
| Document | Date |
|---|---|
| Q1 FY27 earnings call SANOFI INDIA LIMITED – INVESTOR CALL SUMMARY August 5, 2026 --- HEADLINE NUMBERS • Q2 2026 Total Income: +7% YoY growth • Q2 2026 Domestic Sales: + | 2026-08-10 |
| Quarterly results · Q1 FY27 SANOFI INDIA LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS • Q2 2026 Revenue from Operations: ₹4,377 million (8% domestic growth, 6% total growth vs | 2026-08-04 |
| Quarterly results · Q4 FY26 SANOFI INDIA LIMITED – Q1 FY2026 SUMMARY HEADLINE NUMBERS • Q1 FY2026 Revenue from Operations: ₹4,723 million (vs ₹4,198 million in Q4 FY2025; vs ₹5 | 2026-04-28 |
| Annual report FY2025 SANOFI INDIA LIMITED – FY 2025 SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Revenue from operations: ₹18,374 million (FY 2024: ₹20,132 million) – | 2026-04-02 |
| Q3 FY26 earnings call SANOFI INDIA LIMITED – INVESTOR CALL SUMMARY Financial Results for Quarter and Year Ended December 31, 2025 --- HEADLINE NUMBERS • Full Year 2025 D | 2026-03-05 |
| Investor presentation · Q3 FY26 SANOFI INDIA LIMITED - Q4 & FY2025 INVESTOR SUMMARY HEADLINE NUMBERS • Total Income FY2025: ₹20,297 million, down 9% vs ₹18,571 million in FY2024 • | 2026-02-26 |
| Quarterly results · Q3 FY26 SANOFI INDIA LIMITED – DOCUMENT SUMMARY HEADLINE NUMBERS • Total Revenue from Operations (FY 2025): ₹18,374 million (down from ₹20,132 million in FY | 2026-02-25 |
| Q2 FY26 earnings call SANOFI INDIA LIMITED – INVESTOR SUMMARY HEADLINE NUMBERS • Q3 FY2025 (Quarter ended 30 Sept 2025): Profit Before Tax (PBT) showed double-digit growt | 2025-11-04 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹48 / share ex-date Apr 22, 2026 | 2026-04-22 |
| Dividend | ₹75 / share ex-date Nov 7, 2025 | 2025-11-07 |
| Announcement | Date |
|---|---|
| Interim dividend of Rs. 75 per equity share declared Sanofi India Limited's Board of Directors declared an interim dividend of Rs. 75 per equity share on October 29, 2025. Key Details: - Dividend Amount: Rs. 75 per share - Type: Interim divid | 2025-10-29 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Sanofi India Limited — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.